Faculty Information - Māshiyaru Shiyouko

Published papers

Academic conference presentation

Qualifications & licenses

Academic society memberships

Education

Academic & professional experience

（Last updated : 2023-04-10 11:49:10）

Māshiyaru Shiyouko
Department School of Medicine(Tokyo Women's Medical University Adachi Medical Center), School of Medicine

Position Assistant Professor

■ Published papers

1.	Case report	Acute promyelocytic leukemia on hemodialysis successfully treated with all-trans retinoic acid 2023/03
2.	Original article	REGN-COV2 antibody cocktail in patients with SAS-CoV-1: Observational study from a single institution in Japan 2022/03/30
3.	Original article	Prognostic factors in patients with advanced HER2-positive gastric cancer treated with trastuzumab-based chemotherapy: a cohort study 2022/02/20
4.	Original article	Genetic alterations in patients with chronic leukocytosis and persistent thrombocytosis 2022/01/18
5.	Original article	Genetic alterations in patients with chronic leucocytosis and persistent thrombocytosis. 2022
6.	Other	Universal testing for SARS-CoV-2 infection on admission among hospitalized emergency patients: A survey report from a single facility in Tokyo 2021/09/19
7.	Original article	Psychological Effects on Healthcare Workers during the COVID-19 Outbreak: A Single-center Study at a Tertiary Hospital in Tokyo, Japan. 2021/09
8.	Other	Universal testing for SARS-CoV-2 infection on admission among hospitalized emergency patients: A survey report from a single facility in Tokyo. 2021/09
9.	Original article	Impact of omission/reduction of vincristine from R-CHOP in treatment of DLBCL 2021/03
10.	Original article	JAK2-negative acute monocytic leukemia with TET2 mutation in essential thrombocythemia with JAK2 mutation with literature review 2020/01/16
11.	Case report	Type 1 diabetes, ACTH deficiency and hypothyroidism simultaneously induced by nivolumab therapy in a patient with gastric cancer: A Case Report 2020
12.	Original article	Outcome of combination chemotherapy of cetuximab, platinum and fluorouracil to recurrent/metastatic head and neck squamous cell carcinoma 2019/10
13.	Case report	BCL2, BCL6, and MYC-positive intravascular large B-cell lymphoma presenting with bilateral adrenal gland lesions 2019/06
14.	Case report	Seven-Year Outcome of Two Cases of Depression in Elderly High-Altitude Residents in Ladakh, India 2019/06
15.	Original article	Outcome for Advanced or Metastatic Soft Tissue Sarcoma of Nonextremities Treated with Doxorubicin-Based Chemotherapy: A Retrospective Study from a Single Cancer Institution 2018/04
16.	Original article	A comparison of weekly paclitaxel and cetuximab with the EXTREME regimen in the treatment of recurrent/metastatic squamous cell head and neck carcinoma. 2017/10
17.	Case report	Vasodilatation of multiple cerebral arteries in early stage of stroke-like episode with MELAS 2015/02
Display 5 items
Display all(17)

■ Academic conference presentation

1.	Viseral fat mass as prognostic factor in old patients with DLBCL 2022/10/16
2.	Overt pneumonia of Covid-19 one month after the onset in a patient undergoing rituximab maintenance 2022/10/15
3.	Cell-free concentrated ascites reinfusion therapy (CART) for the patients with cancerous ascites: a retrospective report from a single institution 2022/02/18
4.	An Explanatory model for depression in Ladakh, India: A Comparative study using Semi-structured Explanatory Model Interview 2019/10/26
5.	Glucose tolerance change before and after R-CHOP therapy in 15 elderly patients with DLBCL 2019/10/26
6.	Correlation between vital signs and admission rates in elderly patients transported by ambulance; a study from a single hospital in Japan 2019/10/24
7.	The efficacy and safety of SGLT2-inhibitor in elderly patients with type 2 diabetes ; a retrospective review in a single hospital 2019/10/24
8.	Community Social Capital and Depression Among Elderly Highlanders in Ladakh, India 2019/09/29
9.	Impact of omission/reduction of vincristine from R-CHOP therapy in treatment of GCB type DLBCL 2018/06/15
10.	Prognostic factors of trastuzumab based chemotherapy in patients with advanced HER2 positive gastric cancer 2017/01/19
11.	Dose of doxorubicin and outcome for advanced or metastatic soft tissue sarcoma of non-etremities 2016/12/17
Display 5 items
Display all(11)

■ Qualifications & licenses

1.	2019	Board Certified Hematologist
2.	2019/04/01	Medical Oncology
3.	2014	Board Certified Member of the Japanese Society of Internal Medicine
4.	2019	Fellow of the Japanese Society of Internal Medicine

■ Academic society memberships

1.		Japanese Society of Hematology
2.		The Japanese Society of Internal Medicine
3.		The Japanese Society of Medical Oncology

■ Education

〔Doctoral course〕, Tokyo Women's Medical University, Completed,

■ Academic & professional experience

2015/04～2018/03

Expert